Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder

被引:0
|
作者
Aimee M. Hunter
Ian A. Cook
Molly Tartter
Simi K. Sharma
Gregory D. Disse
Andrew F. Leuchter
机构
[1] University of California Los Angeles,Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA
[2] University of California Los Angeles,Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA
[3] University of California Los Angeles,Department of Bioengineering
[4] University of California Los Angeles,Department of Psychology
来源
Psychopharmacology | 2015年 / 232卷
关键词
Antidepressant treatment history; Tachyphylaxis; Tolerance; Placebo response; Antidepressant medication; Randomized clinical trial; Treatment-resistant depression; Expectations;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3833 / 3840
页数:7
相关论文
共 50 条
  • [21] Rosemary as an adjunctive treatment in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Azizi, Saeed
    Mohamadi, Neda
    Sharififar, Fariba
    Dehghannoudeh, Gholamreza
    Jahanbakhsh, Farzaneh
    Dabaghzadeh, Fatemeh
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 49
  • [22] MINAPRINE, AN ATYPICAL ANTIDEPRESSANT DRUG - A PLACEBO-CONTROLLED STUDY IN AGED PATIENTS SUFFERING OF A MAJOR DEPRESSIVE EPISODE
    JOUVENT, R
    BIZIERE, K
    BARUCH, P
    LANCRENON, S
    WIDLOCHER, D
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 417 - 418
  • [23] Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
    Perahia, D. G. S.
    Wang, F.
    Mallinckrodt, C. H.
    Walker, D. J.
    Detke, M. J.
    EUROPEAN PSYCHIATRY, 2006, 21 (06) : 367 - 378
  • [24] Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control
    Ghaffari, Salomeh
    Ghobadi, Ali
    Jamshidi, Amir Hossein
    Mortazavi, Seyyed Hosein
    Naderi, Sina
    Aqamolaei, Ali
    Mortezaei, Amirhosein
    Sahebolzamani, Erfan
    Shamabadi, Ahmad
    Jalilvand, Shakiba
    Daraei, Bahram
    Shalbafan, Mohammad Reza
    Akhondzadeh, Shahin
    ADVANCES IN INTEGRATIVE MEDICINE, 2020, 7 (03) : 141 - 147
  • [25] A PLACEBO-CONTROLLED TRIAL OF PAROXETINE IN THE TREATMENT OF MAJOR DEPRESSION
    SMITH, WT
    GLAUDIN, V
    JOURNAL OF CLINICAL PSYCHIATRY, 1992, 53 : 36 - 39
  • [26] PLACEBO-CONTROLLED TRIAL OF VENLAFAXINE FOR THE TREATMENT OF MAJOR DEPRESSION
    SCHWEIZER, E
    WEISE, C
    CLARY, C
    FOX, I
    RICKELS, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1991, 11 (04) : 233 - 236
  • [27] A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical
    Gaynor, Paula J.
    Gopal, Murali
    Zheng, Wei
    Martinez, James M.
    Robinson, Michael J.
    Marangell, Lauren B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1849 - 1858
  • [28] A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults With Major Depressive Disorder
    Salvadore, Giacomo
    Nash, Abigail
    Bleys, Cathy
    Hsu, Benjamin
    Saad, Ziad
    Gause, Andy
    Moyer, John
    Xi, Liwen
    Manji, Husseini
    Van Nueten, Luc
    Drevets, Wayne
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S292 - S292
  • [29] Randomized, placebo-controlled trial of Fluoxetine for-acute treatment of minor depressive disorder
    Judd, LL
    Rapaport, MH
    Yonkers, KA
    Rush, AJ
    Frank, E
    Thase, ME
    Kupfer, DJ
    Plewes, JM
    Schettler, PJ
    Tollefson, G
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (10): : 1864 - 1871
  • [30] A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    Arnold, LM
    Rosen, A
    Pritchett, YL
    D'Souza, DN
    Goldstein, DJ
    Iyengar, S
    Wernicke, JF
    PAIN, 2005, 119 (1-3) : 5 - 15